For long-time attendees of ObesityWeek, the 2024 conference in San Antonio felt markedly different. In the past, it was an intimate gathering of obesity specialists focused on research and clinical updates. However, as one physician noted, “There’s a lot more suits.” Wall Street has joined the event, drawn by the explosion of interest in the lucrative obesity treatment market. Since…
Tag: Eli Lilly
-
As competition heats up, Novo Nordisk’s share price declines
Danish pharmaceutical giant Novo Nordisk, renowned for its diabetes and weight loss drugs Ozempic and Wegovy, has experienced a significant share price drop of around 19% this month. This decline follows its market peak in June, driven by increasing competition from Eli Lilly, a key player in the same space. Eli Lilly has gained substantial momentum with its rival drugs,…